These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5838971)

  • 1. [Clinical use of a coronary dilator agent: O-(beta-diethylaminoethoxy)-phenylpropiophenone hydrochloride (L.G. 11457)].
    Tudini F; D'Erme E; Rinaldi E
    Gazz Med Ital; 1965 Jun; 124(6):174-7. PubMed ID: 5838971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary observations on the treatment of coronary insufficiency with 2'-(2-diethylaminoethoxy)-3-phenylpropiophenone hydrochloride (LG--11457)].
    CHELLA S
    Minerva Med; 1960 Sep; 51(70 Suppl):2847-52. PubMed ID: 13692742
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experimentation with a new coronary-dilatatory drug: 2'-(2-diethylaminoethoxy)-3-phenylpropiophenone hydrochloride].
    RUGGIERO N; SICA A
    Minerva Med; 1960 Sep; 51(70 Suppl):2871-5. PubMed ID: 13744629
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemical behavior of o-(beta-diethylaminoethoxy)-3-phenylpropiophenone (L.G. 11457)].
    TAURO CS; DI PACO GF
    Boll Chim Farm; 1961 Sep; 100():661-9. PubMed ID: 13919859
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of oxyfedrine in the treatment of coronary disease. Apropos of 100 cases].
    Hiltenbrandt C; Gerard A; Maecker P; Desruelles J
    Lille Med; 1972 Oct; 17(9):1288-93. PubMed ID: 4657642
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of oxyphedrine on ventricular dynamics in ischemic cardiopathy].
    Barbosa J; Lopes AS; Lopes JS; Vergara M; Benchimol AB
    Arq Bras Cardiol; 1972 Jun; 25(3):231-9. PubMed ID: 5079398
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of coronaroactive agents with beta-stimulating effect in ischemic heart disease].
    Kukes VG; Buianov VV; Semenov VN; Abugov AM; Borovkov AI
    Kardiologiia; 1976 Apr; 16(4):88-93. PubMed ID: 16157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of coronary insufficiency with 2'-(2-diethylaminoethoxy)-3-phenylpropiophenone hydrochloride].
    TRIGGIANI G; LATORRE F; BASSI R
    Minerva Med; 1960 Sep; 51(70 Suppl):2852-7. PubMed ID: 13778065
    [No Abstract]   [Full Text] [Related]  

  • 9. [The differential therapy of ischemic heart disease].
    Donat K
    Med Klin; 1968 Nov; 63(45):1793-9. PubMed ID: 5706194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oxyfedrin hydrochloride and taste disorders].
    Grand A
    Nouv Presse Med; 1972 Aug; 1(30):1994. PubMed ID: 5078174
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental and clinical studies with a new coronary and heart-active substance].
    Moll A; Petzel H
    Z Kreislaufforsch; 1967 Jan; 56(1):46-58. PubMed ID: 5595482
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of coronary insufficiency with a combination of a coronary dilator and a beta-adrenergic blockader].
    Grujić M; Perinović M
    Med Arh; 1972; 26(4):267-70. PubMed ID: 4405711
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of a coronary dilator and a digitalis glycoside combination].
    Bazant F; Raberger G
    Wien Klin Wochenschr; 1972 Mar; 84(11):175-81. PubMed ID: 5014174
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect on lipid metabolism of a coronary dilator: ethyl-7-oxyacetate flavone].
    Dupont JC; Sambin P; Detry R; Pont M
    Lyon Med; 1969 Apr; 221(16):941-7. PubMed ID: 5398694
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of oxyphedrine on beriberi-pigeons].
    Jelicić J; Igić R; Stern P
    Arztl Forsch; 1970 Apr; 24(4):116-7. PubMed ID: 5537225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and experimental observations on a group of coronary disease patients treated with an oxadiazole derivative (phenyl-3-diethylaminoethyl-4-imino-5-oxadiazole-1,2,4 hydrochloride)].
    Strobbia R; Manzoni A; Dal Zotto U
    Minerva Med; 1970 Aug; 61(67):3507-15. PubMed ID: 5453990
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical management of coronary insufficiency using Etafenon and its results (report from 3 Berlin hospitals)].
    Pietschmann G
    Dtsch Med J; 1972 Dec; 23(12):713-5. PubMed ID: 4659006
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with the use of high intravenous doses of a coronary-active drug in the treatment of acute and chronic coronary insufficiency].
    Cinelli P; Grazzini M
    Minerva Cardioangiol; 1969 May; 17(5):317-23. PubMed ID: 5814987
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spectrophotometric determination of o-(beta-diethylamino-ethoxy)-phenylpropiophenone HCI in pharmaceutical preparations].
    GIUSTI J; DI PACO GF
    Boll Chim Farm; 1961 Jun; 100():425-9. PubMed ID: 13705842
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease].
    At'kov OIu; Krol VA; Chumburidze VB
    Ter Arkh; 1977; 49(10):57-60. PubMed ID: 22937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.